The markers for this population are largely expressed only in glioma cells (e.g., NFIB, MAP1B, TUBB2B) and they express low levels or have no expression of myeloid/immune markers (CD74, APOE, HLA genes, and CD45). Here, PTPRC is linked to central nervous system cancer.